MBX Biosciences News

MBX Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 17 08:35 ET

MBX Biosciences | 10-K: FY2024 Annual Report

Mar 17 08:15 ET

MBX Biosciences | 8-K: MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 17 08:07 ET

MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director GORDON CARL L

Feb 19 18:01 ET

MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director ORBIMED ADVISORS LLC

Feb 19 17:56 ET

MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Hawryluk P. Kent

Feb 5 16:23 ET

MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Bartram Richard

Feb 5 16:23 ET

MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Azoulay Salomon

Feb 5 16:23 ET

MBX Biosciences | 8-K: Current report

Jan 7 07:24 ET

MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wellington Management Group LLP(9.22%),Wellington Group Holdings LLP(9.22%), etc.

Nov 8, 2024 10:55 ET

MBX Biosciences | 10-Q: Quarterly report

Nov 7, 2024 08:33 ET

MBX Biosciences | 8-K: MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7, 2024 08:13 ET

MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-P. Kent Hawryluk(5.55%)

Nov 1, 2024 17:42 ET

MBX Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-Norwest Venture Partners XVI, LP(6.4%),Genesis VC Partners XVI, LLC(6.4%), etc.

Sep 23, 2024 18:09 ET

MBX Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-New Enterprise Associates 17, L.P.(11.4%),NEA Partners 17, L.P.(11.4%), etc.

Sep 23, 2024 18:09 ET

MBX Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%), etc.

Sep 23, 2024 16:38 ET

MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.48%),Deep Track Biotechnology Master Fund, Ltd.(9.48%), etc.

Sep 23, 2024 16:04 ET

MBX Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-James N. Topper(18.8%),Patrick J. Heron(18.8%), etc.

Sep 23, 2024 10:53 ET

MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.(5.62%)

Sep 20, 2024 10:17 ET

MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Mathers Edward T

Sep 17, 2024 20:30 ET